Cargando…
P86. THE IMPLANT RELATED MORTALITY RISK AND THE RATIONALE FOR PROPHYLACTIC EXPLANATION OF PATIENTS AT HIGH RISK OF BIA-ALCL
Autor principal: | di Pompeo, Fabio Santanelli |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8984415/ http://dx.doi.org/10.1097/01.GOX.0000828692.86713.29 |
Ejemplares similares
-
Mortality Rate in Breast Implant Surgery: Is an Additional Procedure Worthwhile to Mitigate BIA-ALCL Risk?
por: Santanelli di Pompeo, Fabio, et al.
Publicado: (2022) -
10. Breast Implant-associated Anaplastic Large Cell Lymphoma (BIA-ALCL) Prevalence in a Cohort of 1,508 Patients from a Private Cosmetic Practice
por: Santanelli di Pompeo, Fabio, et al.
Publicado: (2023) -
P38. THERAPEUTIC VS. PROPHYLACTIC BILATERAL MASTECTOMIES: COMPLICATIONS AND TRENDS IN THE UNITED STATES
por: Shaheen, Mohammed, et al.
Publicado: (2022) -
P151. PREVENTION OF BREAST CANCER RELATED LYMPHEDEMA WITH PROPHYLACTIC LYMPH NODE TRANSFER: PRELIMINARY RESULTS OF A PROSPECTIVE STUDY
por: Chang, Edward I., et al.
Publicado: (2022) -
P56. FACTORS ASSOCIATED WITH IMPLANT FLIPPING IN IMMEDIATE BREAST RECONSTRUCTION
por: Leibl, Kayla E., et al.
Publicado: (2022)